Comparison of second-trimester maternal serum free-β-human chorionic gonadotropin and α-fetoprotein between normal singleton and twin pregnancies: A population-based study

Chinese Medical Journal

Volumn 123, Issue 5, 2010, Pages 555-558

  Zheng, Ming Ming ^a   Hu, Ya Li ^a   Zhang, Chun Yan ^a   Ru, Tong ^a   Liu, Qi Lan ^a   Xu, Bi Yun ^a   Chen, Qi Guang ^a   Xu, Zheng Feng ^a   Zhang, Yin ^a   Zhong, Xiao Ling ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Alpha fetoproteins; Chorionic gonadotropin; Pregnancy trimester, second; Prenatal screening; Twin pregnancy

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ANENCEPHALUS; ARTICLE; CONTROLLED STUDY; FEMALE; FLUOROIMMUNOASSAY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; NEURAL TUBE DEFECT; PRENATAL SCREENING; PROTEIN ANALYSIS; SECOND TRIMESTER PREGNANCY; TRISOMY 18; TRISOMY 21; TWIN PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; TWINS;

EID: 77949393663     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.05.009     Document Type: Article

References (20)

1. Muller F, Dreux S, Dupoizat H, Uzan S, Dubin MF, Oury JF, et al. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity. Prenat Diagn 2003; 23: 331-335.
2. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics; Society for Maternal-Fetal Medicine; ACOG Joint Editorial Committee. ACOG Practice Bulletin #56: Multiple gestation: complicated twin, triplet, and high-order multifetal pregnancy. Obstet Gynecol 2004; 104: 869-883.
3. Odibo AO, Lawrence-Cleary K, Macones GA. Screening for aneuploidy in twins and higher order multiples: is first-trimester nuchal translucency the solution? Obstet Gynecol Surv 2003; 58: 609-614.
4. Spencer K, Salonen R, Muller F. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein, free beta hCG. Prenat Diagn 1994; 14: 537-542.
5. Wald NJ, Densem JW. Maternal serum free ß-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Prenat Diagn 1994; 14: 319-320.
6. Barnabei VM, Krantz DA, Macri JN, Larsen JW. Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hCG and AFP. Prenat Diagn 1995; 15: 1131-1134.
7. Neveux LM, Palom GE, Knight GJ, Haddow JE. Multiple marker screening for Down syndrome in twin pregnancies. Prenat Diagn 1996; 16: 29-34.
8. O'Brien JE, Dvorin E, Yaron Y, Ayoub M, Johnson MP, Hume RF Jr, et al. Differential increases in AFP, hCG and uE3 in twin pregnancies: impact on attempts to quantify Down syndrome screening calculations. Am J Med Genet 1997; 73: 109-112.
9. Xie Z, Lu S, Zhu Y, Sun Y, Jin Y. Second-trimester maternal serum free-β-human chorionic gonadotrophin and α-fetoprotein levels in normal twin and singleton pregnancies: a report of local Chinese population. Prenat Diagn 2008; 28: 735-738.
10. O'Brien JE, Dvorin E, Drugan A, Johnson MP, Yaron Y, Evans MI. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol. Obstet Gynecol 1997; 89: 355-338.
11. Hu YL, Birth Defect Intervention Group of Jiangsu Province. Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26 803 pregnant women in Jiangsu Province. Natl Med J China (Chin) 2007; 87: 2476-2480.
12. Zheng MM, Hu Y, Liu QL, Xu BY, Chen QG. Second trimester neural tube defects maternal serum marker screening. Results of Jiangsu province study. Chin J Birth Health Heredity (Chin) 2007; 15: 87-89.
13. Wald NJ, Rish S. Prenatal screening for Down syndrome and neural tube defects in twin pregnancies. Prenat Diagn 2005; 25: 740-745.
14. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109: 217-227.
15. Niemimaa M, Suonpää M, Heinonen S, Seppälä M, Bloigu R, Ryynänen M. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimester. Prenat Diagn 2002; 22: 183-185.
16. Palomaki GE, Lee JE, Canick JA, McDowell GA, Donnenfeld AE. Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements. Genet Med 2009; 11: 669-681.
17. Wang YY, Luo J, Zhu MW, Liu LN, Ma X. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations. Int J Gynaecol Obstet 2006; 94: 67-72.
18. Xu BY, Hu Y, Zhang CY, Zhang JW, Liu QL, Yue H. Evaluating the applicability of MoM in second trimester maternal serum to screening for Down's syndrome in Jiangsu province. Chin J Med Genet (Chin) 2008; 25: 32-35.
19. Kevin S, Karl OK, Kypros HN. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Prenat Diagn 2008; 28: 49-52.
20. Aurelie GB, Sophie D, Nathalie L, Jean FO, Francoise M. Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies. Prenat Diagn 2008; 28: 1105-1109.